FDx Advisors Inc. raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 13.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,609 shares of the company’s stock after buying an additional 1,409 shares during the period. FDx Advisors Inc.’s holdings in Henry Schein were worth $811,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. FTB Advisors Inc. increased its stake in shares of Henry Schein by 100.0% during the 3rd quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock worth $120,000 after purchasing an additional 742 shares in the last quarter. Lee Financial Co increased its stake in shares of Henry Schein by 100.0% during the 3rd quarter. Lee Financial Co now owns 1,756 shares of the company’s stock worth $144,000 after purchasing an additional 878 shares in the last quarter. Advisory Services Network LLC increased its stake in shares of Henry Schein by 430.1% during the 4th quarter. Advisory Services Network LLC now owns 2,099 shares of the company’s stock worth $147,000 after purchasing an additional 1,703 shares in the last quarter. Westside Investment Management Inc. increased its stake in shares of Henry Schein by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 2,000 shares of the company’s stock worth $160,000 after purchasing an additional 1,000 shares in the last quarter. Finally, JNBA Financial Advisors increased its stake in shares of Henry Schein by 100.0% during the 3rd quarter. JNBA Financial Advisors now owns 2,000 shares of the company’s stock worth $164,000 after purchasing an additional 1,000 shares in the last quarter. 88.58% of the stock is owned by institutional investors.
A number of research analysts have recently weighed in on HSIC shares. Bank of America started coverage on shares of Henry Schein in a research note on Tuesday. They set a “neutral” rating and a $76.00 price objective for the company. Zacks Investment Research cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, November 13th. Stifel Nicolaus dropped their price objective on shares of Henry Schein from $89.00 to $77.00 and set a “hold” rating for the company in a research note on Tuesday, November 7th. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Finally, Evercore ISI started coverage on shares of Henry Schein in a research note on Thursday, January 4th. They set an “outperform” rating and a $81.00 price objective for the company. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $83.07.
Shares of Henry Schein, Inc. (HSIC) opened at $66.19 on Thursday. The company has a market cap of $10,329.79, a P/E ratio of 18.69, a price-to-earnings-growth ratio of 1.65 and a beta of 1.00. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 0.32. Henry Schein, Inc. has a 12 month low of $63.01 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 20th. The company reported $0.97 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.97. The firm had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.30 billion. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. Henry Schein’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.94 EPS. equities analysts anticipate that Henry Schein, Inc. will post 4.08 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3230257/henry-schein-inc-hsic-shares-bought-by-fdx-advisors-inc.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.